BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16949381)

  • 1. Strategies to reduce the risk of contrast-induced nephropathy.
    Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):59K-77K. PubMed ID: 16949381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast nephropathy in children.
    Verghese PS
    J Pediatr Intensive Care; 2014 Jun; 3(2):45-52. PubMed ID: 31214451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy.
    Meschi M; Detrenis S; Musini S; Strada E; Savazzi G
    Crit Care Med; 2006 Aug; 34(8):2060-8. PubMed ID: 16763513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk situations and procedures.
    Becker CR; Davidson C; Lameire N; McCullough PA; Stacul F; Tumlin J; Adam A;
    Am J Cardiol; 2006 Sep; 98(6A):37K-41K. PubMed ID: 16949379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast media nephrotoxicity--the story so far.
    Morcos SK
    Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
    Cox CD; Tsikouris JP
    J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prognostic implications of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):5K-13K. PubMed ID: 16949375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of contrast media-induced nephrotoxicity after angiographic procedures.
    Morcos SK
    J Vasc Interv Radiol; 2005 Jan; 16(1):13-23. PubMed ID: 15640403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of contrast-induced nephropathy: an overview.
    Ellis JH; Cohan RH
    Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of pharmacologic interventions to prevent contrast-induced nephropathy.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S34-42. PubMed ID: 14668708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing contrast medium-induced nephropathy.
    Kohtz C; Thompson M
    Am J Nurs; 2007 Sep; 107(9):40-9; quiz 49-50. PubMed ID: 17721148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.